Author

Esther Fernández‐Simón

Observed names: E. Fernandez Simon, E. Fernández Simón, E. Fernández-Simón, Esther Fernandez Simon, Esther Fernandez-Simon, Esther Fernández-Simon, Esther Fernández-Simón, Fernandez Simon, Esther, Fernández Simón, Esther, Fernández-Simón, Esther

Institutions: Centre for Life, Newcastle University

Observed institutions: Universitat Autònoma de Barcelona, Newcastle upon Tyne Hospitals NHS Foundation Trust, Hospital de Sant Pau, Centre for Life, Centre for Biomedical Network Research on Rare Diseases, Centro de Investigación Biomédica en Red, Muscular Dystrophy UK, Institut de Recerca Sant Pau, Newcastle University

ORCID: 0000-0003-4804-6553

Observed ORCID: 0000-0003-4804-6553

OpenAlex ID: A5029064247

Decoding the transcriptome of Duchenne muscular dystrophy to the single nuclei level reveals clinical-genetic correlations

2023 · Xavier Suárez-Calvet, Esther Fernández-Simón, et al. · Cell Death and Disease · 48

Nintedanib decreases muscle fibrosis and improves muscle function in a murine model of dystrophinopathy

2018 · Patricia Piñol-Jurado, Xavier Suárez-Calvet, et al. · Cell Death and Disease · 48

Platelet-Derived Growth Factor BB Influences Muscle Regeneration in Duchenne Muscle Dystrophy

2017 · Patricia Piñol-Jurado, Eduard Gallardo, et al. · American Journal Of Pathology · 48

Identification of serum microRNAs as potential biomarkers in Pompe disease

2019 · Ana Carrasco‐Rozas, Esther Fernández‐Simón, et al. · Annals of Clinical and Translational Neurology · 32

RhoA/ROCK2 signalling is enhanced by PDGF‐AA in fibro‐adipogenic progenitor cells: implications for Duchenne muscular dystrophy

2022 · Esther Fernández‐Simón, Xavier Suárez‐Calvet, et al. · Journal of Cachexia Sarcopenia and Muscle · 26

Thrombospondin-1 mediates muscle damage in brachio-cervical inflammatory myopathy and systemic sclerosis

2020 · Xavier Suárez-Calvet, Jorge Alonso-Pérez, et al. · Neurology Neuroimmunology & Neuroinflammation · 25

Single cell RNA sequencing of human FAPs reveals different functional stages in Duchenne muscular dystrophy

2024 · Esther Fernández-Simón, Patricia Piñol-Jurado, et al. · Frontiers in Cell and Developmental Biology · 20

PDGF-BB serum levels are decreased in adult onset Pompe patients

2019 · Esther Fernández-Simón, Ana Carrasco-Rozas, et al. · Scientific Reports · 19

Nintedanib Reduces Muscle Fibrosis and Improves Muscle Function of the Alpha-Sarcoglycan-Deficient Mice

2022 · Jorge Alonso-Pérez, Ana Carrasco-Rozas, et al. · Biomedicines · 17

Isolation of human fibroadipogenic progenitors and satellite cells from frozen muscle biopsies

2021 · Xavier Suárez‐Calvet, Esther Fernández‐Simón, et al. · The FASEB Journal · 16

Myostatin and follistatin as monitoring and prognostic biomarkers in dysferlinopathy

2023 · Ursula Moore, Esther Fernández-Simón, et al. · Neuromuscular Disorders · 13

Study of the effect of anti-rhGAA antibodies at low and intermediate titers in late onset Pompe patients treated with ERT

2019 · Esther Fernández-Simón, Ana Carrasco-Rozas, et al. · Molecular Genetics and Metabolism · 11

Decoding the muscle transcriptome of patients with late-onset Pompe disease reveals markers of disease progression

2024 · Alexandra Monceau, Rasya Gokul Nath, et al. · Brain · 10

Imaging mass cytometry analysis of Becker muscular dystrophy muscle samples reveals different stages of muscle degeneration

2024 · Patricia Piñol-Jurado, José Verdú-Díaz, et al. · Scientific Reports · 10

BNIP3 Is Involved in Muscle Fiber Atrophy in Late-Onset Pompe Disease Patients

2022 · Ana Carrasco-Rozas, Esther Fernández-Simón, et al. · American Journal Of Pathology · 8

Platelet Derived Growth Factor-AA Correlates With Muscle Function Tests and Quantitative Muscle Magnetic Resonance in Dystrophinopathies

2021 · Alicia Alonso-Jiménez, Esther Fernández-Simón, et al. · Frontiers in Neurology · 8

Effect of MAPK Inhibition on the Differentiation of a Rhabdomyosarcoma Cell Line Combined With CRISPR/Cas9 Technology: An In Vitro Model of Human Muscle Diseases

2018 · Noemí De Luna, Xavier Suarez-Calvet, et al. · Journal of Neuropathology & Experimental Neurology · 8

Proteasome inhibitors reduce thrombospondin-1 release in human dysferlin-deficient myotubes

2020 · Esther Fernández-Simón, Cinta Lleixà, et al. · BMC Musculoskeletal Disorders · 6

Strategy for drug repurposing in fibroadipogenic replacement during muscle wasting: application to duchenne muscular dystrophy

2025 · Izzy Matthews, Priyanka Mehra, et al. · Frontiers in Cell and Developmental Biology · 3

Impact of C4BPA on Muscle progenitor cell differentiation: insights for Duchenne muscular dystrophy treatment

2026 · Esther Fernández-Simón, Ainoa Tejedera-Villafranca, et al. · Cell Death and Disease · 1

Investigating the role of EGFR signalling in muscle dystrophies: implications for Duchenne muscular dystrophy

2026 · Esther Fernández-Simón, Ainoa Tejedera-Villafranca, et al. · Cell Death and Disease · 1

P.61 Imaging Mass Cytometry reveals new clues to understand the pathogenesis of Becker muscular dystrophy

2022 · P. Piñol, J. Verdú-Díaz, et al. · Neuromuscular Disorders · 1

BNIP3 is involved in muscle fiber atrophy in late-onset Pompe disease patients

2022 · Jordi Diaz-Manera, Ana Carrasco, et al. · Molecular Genetics and Metabolism · 1

SP13 Impact of C4BPA on muscle progenitor cell differentiation: insights for Duchenne muscular dystrophy treatment

2026 · Esther Fernandez-Simon, Ainoa Tejedera-Villafranca, et al. · Neuromuscular Disorders

SP46 The extracellular matrix as a driver of muscle degeneration in sarcoglycanopathies: a human proteomic study

2026 · James Clark, Esther Fernandez-Simon, et al. · Neuromuscular Disorders

Works count: 59

Citation count: 380

H-index: 11

I10-index: 14